|Six months ended 31 December 2018 (Unaudited)||Six months ended 31 December 2017 (Unaudited)||
|Adjusted EBITDA (£m) 1||23.8||24.0||(0.8)|
|Adjusted profit before income tax (£m) 2||17.4
|Adjusted basic earnings per share (pence) 3||19.7||22.9||(14.0)|
|Operating profit (£m)||3.4||8.1||(58.0)|
|Profit before income tax (£m)||1.6||6.2||(74.2)|
|Basic earnings per share (pence)||1.2||7.8||(84.6)|
- Sales growth of 23.7%
- Like-for-like sales increase of 4.0%
- Adjusted EBITDA down at £23.8m (0.8%)
- Adjusted EPS down to 19.7p (14.0%)
- Net debt as at 31 December 2018 of £116.8m (30 June 2018: £69.0m)
- 23 practice surgeries acquired during the period
1 Adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) is profit before income tax, net finance expense, depreciation, amortisation, costs relating to business combinations and exceptional items.
2 Adjusted profit before income tax is calculated as profit on ordinary activities before amortisation, taxation, costs relating to business combinations and exceptional items.
3 Adjusted earnings per share is calculated as adjusted profit before income tax less applicable taxation divided by the weighted average number of ordinary shares in issue during the period.
4 Percentage increases and decreases have been calculated throughout this document based on the underlying values.